Kraj: Unia Europejska
Język: angielski
Źródło: EMA (European Medicines Agency)
inactivated influenza-A virus / swine
CEVA Santé Animale
QI09AA03
inactivated influenza-A virus, swine
Pigs
Immunologicals
Active immunisation of pigs from the age of 56 days onwards, including pregnant sows, against swine influenza caused by subtypes H1N1, H3N2 and H1N2 to reduce clinical signs and viral lung load after infection.Onset of immunity: 7 days after primary vaccinationDuration of immunity: 4 months in pigs vaccinated between the age of 56 and 96 days and 6 months in pigs vaccinated for the first time at 96 days and above.Active immunisation of pregnant sows after finished primary immunisation by administration of a single dose 14 days prior to farrowing to develop high colostral immunity, which provides clinical protection of piglets for at least 33 days after birth.
Revision: 5
Authorised
2010-01-14
18 B. PACKAGE LEAFLET 19 PACKAGE LEAFLET: RESPIPORC FLU3 Suspension for injection for pigs 1. NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF THE MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE, IF DIFFERENT Marketing authorisation holder Ceva Santé Animale 10 av. de La Ballastière 33500 Libourne France Manufacturer responsible for batch release: IDT Biologika GmbH Am Pharmapark 06861 Dessau-Rosslau Germany Ceva-Phylaxia Veterinary Biologicals Co. Ltd. Szállás u. 5. 1107 Budapest Hungary 2. NAME OF THE VETERINARY MEDICINAL PRODUCT Respiporc FLU3 suspension for injection for pigs 3. STATEMENT OF THE ACTIVE SUBSTANCES AND OTHER INGREDIENTS Each dose of 2 ml contains: ACTIVE SUBSTANCES: Strains of inactivated Influenza A virus/swine/ Bakum/IDT1769/2003 (H3N2) ≥ 10.53 log 2 GMNU 1 Haselünne/IDT2617/2003 (H1N1) ≥ 10.22 log 2 GMNU 1 Bakum/1832/2000 (H1N2) ≥ 12.34 log 2 GMNU 1 1 GMNU = Geometric mean of neutralizing units induced in Guinea pigs after twice immunisation with 0.5 ml of this vaccine ADJUVANT: Carbomer 971 P NF 2.0 mg 20 EXCIPIENT: Thiomersal 0.21 mg Clear, yellowish orange to pink coloured suspension for injection. 4. INDICATION(S) Active immunisation of pigs from the age of 56 days onwards including pregnant sows against swine influenza caused by subtypes H1N1, H3N2 and H1N2 to reduce clinical signs and viral lung load after infection. Onset of immunity: 7 days after primary vaccination Duration of immunity: 4 months in pigs vaccinated between the age of 56 and 96 days and 6 months in pigs vaccinated for the first time at 96 days and above. Active immunisation of pregnant sows after finished primary immunisation by administration of a single dose 14 days prior to farrowing to develop high colostral immunity which provides clinical protection of piglets for at least 33 days after birth. 5. CONTRAINDICATIONS None. 6. ADVERSE REACTIONS A transient slight swelling may occur on very rare occasions after vaccination at the site of injection, regressing within 2 days. On Przeczytaj cały dokument
1 ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 2 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Respiporc FLU3 suspension for injection for pigs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of 2 ml contains: ACTIVE SUBSTANCES: Strains of inactivated Influenza A virus/swine/ Bakum/IDT1769/2003 (H3N2) ≥ 10.53 log 2 GMNU 1 Haselünne/IDT2617/2003 (H1N1) ≥ 10.22 log 2 GMNU 1 Bakum/1832/2000 (H1N2) ≥ 12.34 log 2 GMNU 1 1 GMNU = Geometric mean of neutralizing units induced in Guinea pigs after twice immunisation with 0.5 ml of this vaccine ADJUVANT: Carbomer 971 P NF 2.0 mg EXCIPIENT: Thiomersal 0.21 mg For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Clear, yellowish orange to pink coloured suspension for injection. 4. CLINICAL PARTICULARS 4.1. TARGET SPECIES Pigs 4.2. INDICATION FOR USE, SPECIFYING THE TARGET SPECIES Active immunisation of pigs from the age of 56 days onwards including pregnant sows against swine influenza caused by subtypes H1N1, H3N2 and H1N2 to reduce clinical signs and viral lung load after infection. Onset of immunity: 7 days after primary vaccination Duration of immunity: 4 months in pigs vaccinated between the age of 56 and 96 days and 6 months in pigs vaccinated for the first time at 96 days and above. 3 Active immunisation of pregnant sows after finished primary immunisation by administration of a single dose 14 days prior to farrowing to develop high colostral immunity which provides clinical protection of piglets for at least 33 days after birth. 4.3. CONTRAINDICATIONS None. 4.4. SPECIAL WARNINGS FOR EACH TARGET SPECIES None. 4.5. SPECIAL PRECAUTIONS FOR USE Special precautions for use in animals Not applicable. Special precautions to be taken by the person administering the veterinary medicinal product to animals In case of accidental self-injection only a minor injection site reaction is expected. 4.6. ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS) A transient slight swelling may occur on very rare occasions after vaccination at the site of injection, reg Przeczytaj cały dokument